Skip to content
Agentic OS
Menu

Intelligence / Healthtech / Device Recalls / Beckman Coulter INC.

QualityClass II recall14 Oct 2026

Beckman Coulter INC.

14 Oct 2026: Class II recall · DxC 500 AU Clinical Chemistry Analyzers: 1. AU w/out ISE, Part No. C63519 2. AU w/ISE, Part No. C63520. Recorded in the openFDA device enforcement reports.

View the source record

Reported
14 Oct 2026
Recall Class
Class II
Product
DxC 500 AU Clinical Chemistry Analyzers: 1. AU w/out ISE, Part No. C63519 2. AU w/ISE, Part No. C63520
Reason
Beckman Coulter has identified a software issue affecting DxC 500 AU Clinical Analyzers when testing plasma samples. Following user configuration of a Clinical Chemistry test to use units different from the system default, a subsequent conf
Country
United States
Status
Ongoing
Reference
Z-0084-2027
Location
Brea, CA
What this signal means

A recall puts quality, regulatory, field service and communications under pressure at once.

  1. Class II leads with 660 of 741, then Class I (68).
  2. 235 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Beckman Coulter INC.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this quality signal, for your approval.

Start free

Across AOS Research

Other records for Beckman Coulter INC. in our registers.

More in Class II

Device Recalls

See all

Source: openFDA device enforcement reports, data to 18 Nov 2026. Device recalls classified by FDA, by report date. Class I is the most serious. AOS shows what the public record says; it does not verify or endorse the company.